F.D.A. Approves New Nasal Spray for Migrainesnews2023-03-10T18:37:27+00:00March 10th, 2023|The New York Times|
Walgreens Faces Blowback for Not Offering Abortion Pill in 21 Statesnews2023-03-08T02:48:07+00:00March 8th, 2023|The New York Times|
Preterm Birth Drug Withdrawn After 12 Yearsnews2023-03-08T01:17:50+00:00March 8th, 2023|The New York Times|
Could the Next Blockbuster Drug Be Lab-Rat Free?news2023-03-07T08:00:08+00:00March 7th, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
12 States Sue F.D.A., Seeking Removal of Special Restrictions on Abortion Pillnews2023-02-24T23:20:38+00:00February 24th, 2023|The New York Times|
A Fraught New Frontier in Telehealth: Ketaminenews2023-02-20T08:00:06+00:00February 20th, 2023|The New York Times|
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Concludenews2023-02-16T01:23:11+00:00February 16th, 2023|The New York Times|
Covid Vaccines Targeting Omicron Should Be Standard, Panel Saysnews2023-01-26T22:46:39+00:00January 26th, 2023|The New York Times|
Why Kids’ Medication Shortages Aren’t Going Awaynews2023-01-19T00:33:55+00:00January 19th, 2023|The New York Times|
